Integrated Cellular and Plasma Proteomics of Contrasting B-Cell Cancers Reveals Common, Unique and Systemic Signatures*□S

Total Page:16

File Type:pdf, Size:1020Kb

Integrated Cellular and Plasma Proteomics of Contrasting B-Cell Cancers Reveals Common, Unique and Systemic Signatures*□S crossmark Research © 2017 by The American Society for Biochemistry and Molecular Biology, Inc. This paper is available on line at http://www.mcponline.org Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures*□S Harvey E. Johnston‡§, Matthew J. Carter‡, Kerry L. Cox‡, Melanie Dunscombe‡, Antigoni Manousopoulou§¶, Paul A. Townsendʈ, Spiros D. Garbis§¶, and Mark S. Cragg‡** Approximately 800,000 leukemia and lymphoma cases are both subunits of the interleukin-5 (IL5) receptor. IL5 treat- diagnosed worldwide each year. Burkitt’s lymphoma (BL) ment promoted E␮-TCL1 tumor proliferation, suggesting and chronic lymphocytic leukemia (CLL) are examples of an amplification of IL5-induced AKT signaling by TCL1. contrasting B-cell cancers; BL is a highly aggressive Tumor plasma contained a substantial tumor lysis signa- Downloaded from lymphoid tumor, frequently affecting children, whereas ture, most prominent in E␮-myc plasma, whereas E␮- CLL typically presents as an indolent, slow-progressing TCL1 plasma contained signatures of immune-response, leukemia affecting the elderly. The B-cell-specific overex- inflammation and microenvironment interactions, with pression of the myc and TCL1 oncogenes in mice induce putative biomarkers in early-stage cancer. These findings spontaneous malignancies modeling BL and CLL, respec- provide a detailed characterization of contrasting B-cell http://www.mcponline.org/ tively. Quantitative mass spectrometry proteomics and tumor models, identifying common and specific tumor isobaric labeling were employed to examine the biology mechanisms. Integrated plasma proteomics allowed the underpinning contrasting E␮-myc and E␮-TCL1 B-cell tu- dissection of a systemic response and a tumor lysis sig- mors. Additionally, the plasma proteome was evaluated nature present in early- and late-stage cancers, respec- using subproteome enrichment to interrogate biomarker tively. Overall, this study suggests common B-cell cancer emergence and the systemic effects of tumor burden. signatures exist and illustrates the potential of the further Over 10,000 proteins were identified (q<0.01) of which evaluation of B-cell cancer subtypes by integrative 8270 cellular and 2095 plasma proteins were quantita- proteomics. Molecular & Cellular Proteomics 16: by guest on September 10, 2018 tively profiled. A common B-cell tumor signature of 695 10.1074/mcp.M116.063511, 386–406, 2017. overexpressed proteins highlighted ribosome biogenesis, cell-cycle promotion and chromosome segregation. E␮- myc tumors overexpressed several methylating enzymes Burkitt’s lymphoma (BL)1 and chronic lymphocytic leukemia ␮ and underexpressed many cytoskeletal components. E - (CLL) represent the extremes of B cell cancers; BL is highly TCL1 tumors specifically overexpressed ER stress re- aggressive and frequently affects children, whereas CLL typ- sponse proteins and signaling components in addition to ically presents as an indolent, slow-progressing leukemia in the elderly (1, 2). From the ‡Antibody and Vaccine Group, Cancer Sciences Unit, BL is a hallmark myc-driven tumor; induced by chromo- Faculty of Medicine, General Hospital, University of Southampton, somal translocation of the transcription factor myc to immu- Southampton SO16 6YD, UK; §Centre for Proteomic Research, Insti- noglobulin (Ig) enhancers (3). Myc influences ϳ15% of the tute for Life Sciences, University of Southampton, Highfield Campus, genome, regulating processes such as cell proliferation, me- Southampton, SO17 1BJ, UK; ¶Clinical and Experimental Sciences tabolism, adhesion, angiogenesis and de-differentiation (4– Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK; ʈMolecular and Clinical Cancer Sciences, Paterson 6). Such neoplastic-like traits make myc an aggressive onco- Building, Manchester Cancer Research Centre, Manchester Aca- gene, dysregulated or overexpressed in most cancers (7). demic Health Science Centre, University of Manchester, Manchester, Formal proof of its oncogenic properties were demonstrated M20 4BX when human myc was placed into the ␮ Ig heavy chain Received August 27, 2016, and in revised form, December 19, 2016 enhancer (E␮) region of the mouse. These ‘E␮-myc’ mice Published, MCP Papers in Press, January 4, 2017, DOI 10.1074/ mcp.M116.063511 Author contributions: Conceptualization: H.E.J., P.A.T., S.D.G., and 1 The abbreviations used are: BL, Burkitt’s lymphoma; CLL, M.S.C. Methodology: H.E.J. Validation: H.E.J. and M.J.C. Formal Chronic lymphocytic leukaemia; DEP, Differentially expressed pro- analysis: H.E.J. Investigation: H.E.J. Resources: H.E.J., M.D., K.L.C., tein; E␮, ␮ Ig heavy chain enhancer; Ig, Immunoglobulin; iTRAQ, A.M., and S.D.G. Writing – Original draft: H.E.J. and M.S.C. Writing – Isobaric tags for relative and absolute quantitation; Rs, Regulation ϩ Review & Editing: H.E.J., M.S.C., and M.J.C. Visualization: H.E.J. score (mean of log2(ratios)/(SD of log2(ratios) 1)); SEC, Size exclu- Supervision: M.S.C., P.A.T., and S.D.G. Funding Acquisition: M.S.C., sion chromatography; SuPrE, Subproteome enrichment; TMT, Tan- P.A.T., and H.E.J. dem mass tags; WT, Wild type. 386 Molecular & Cellular Proteomics 16.3 Cellular and Plasma Proteomics of B-cell Tumors produced high-penetrance lymphomas within around 100 (WT) mice. The resulting proteomes have been interrogated to days, recapitulating several molecular and pathological as- identify common and tumor-specific signatures and to under- pects of BL (3, 8–10). stand the combined cellular and extracellular characteristics In contrast, CLL is a relatively indolent B-cell cancer, pre- of B-cell tumors. senting with a CD5ϩCD19ϩ leukemia (11, 12). Up to 90% of CLL cases express TCL1—a protein involved in lymphocyte MATERIALS AND METHODS development (13–15). TCL1 is suggested to promote cell sur- Materials—Tris(hydroxymethyl)aminomethane (TRIS), SDS, vival and proliferation by amplification of AKT phosphoryla- Na2EDTA, NH4Cl, NaHCO3, sodium deoxycholate (DOC), tion, induced by growth factor-, cytokine- and B-cell receptor- guanidine hydrochloride, glycine, HPLC and LC-MS grade induced PI3K signaling (16, 17). The E␮-TCL1 mouse, ACN and formic acid (FA) and 100 ␮m cell sieves were pur- overexpressing TCL1 in B-cells again through the ␮ enhancer, chased from Fisher Scientific, Loughborough, UK. Tween20 was developed as a potential model of CLL (18). E␮-TCL1 (tween), sodium heparin, propidium iodide (PI), carboxyfluo- mice recapitulate the expanded bone marrow, splenic and rescein succinimidyl ester (CFSE), asparagine, 2-mercapto- circulatory CD5ϩ B-cell populations of CLL, detectable from ethanol, octylphenoxypolyethoxyethanol (IgePalCA630), triton around 3–5 months of age. The disease progresses to lethal x-100, protease inhibitors, ponceau S, acetic acid, methyl splenomegaly and leukemia at ϳ12 months (18, 19). Currently methanethiosulfonate (MMTS), tris(2-carboxyethyl)phosphine it is regarded as one of the most useful preclinical models of (TCEP), triethylammonium bicarbonate (TEAB), DMSO, hy- Downloaded from CLL (20, 21). droxylamine and ammonium hydroxide (NH4OH) were pur- Together, these models provide the opportunity to study chased from Sigma, St. Louis, MO. oncogenesis mediated by two contrasting oncogenes at op- Dulbecco’s modified Eagle’s medium (DMEM), glutamine, posing ends of the proliferative spectrum. E␮-myc tumors, pyruvate, penicillin and streptomycin were purchased from like BL, are highly aggressive, have rapid onset and form Life Technologies, Carlsbad, CA. Mouse B-cell isolation kits http://www.mcponline.org/ lymphoid tumors, whereas E␮-TCL1 mice, like CLL, present a and magnetic cell sorting columns were purchased from relatively indolent and slow-developing leukemia with sec- Miltenyi Biotech, Bergisch Gladbach, Germany. Twenty- ondary lymphoid organ involvement (3, 18). three-gauge needles and 1-ml syringes were purchased from In addition to cellular characterizations of tumors, plasma BD Biosciences, Franklin Lakes, NJ, Interleukin 5 (IL5) recom- analysis holds the potential to identify additional biological binant protein from Peprotech, Rocky Hill, NJ, Immobilon 0.45 signatures arising during oncogenesis. In particular, extracel- ␮m pore PVDF membrane from Millipore, Billerica, MA and lular fluids can provide insight into the tumor-host dialogue nonfat milk from Marvel, Birmingham, UK. 30ϫ DTT and 3ϫ by guest on September 10, 2018 between the immune system and micro-environment and re- red loading buffer were purchased for Cell Signaling Technol- port on the metabolic and homeostatic aberrations that tu- ogies, Danvers, MA. Enhanced chemiluminescence reagents, mors display. Further, combining cellular and plasma charac- tandem mass tags (TMT) 10-plex isobaric labeling reagents terization can provide greater insight into the mechanisms and 2 kDa Mw cut-off Slide-A-Lyzer dialysis cassettes and by which any biomarkers of disease may be entering the proteomics grade lys-c were purchased from Thermo Scien- circulation. tific, Waltham, MA. Proteomics grade trypsin was purchased Liquid chromatography coupled with mass spectrometry from Roche, Basel, Switzerland. Isobaric tags for relative and (LC-MS) proteomics currently provides the best means of absolute quantitation (iTRAQ) 8-plex reagents were pur- establishing global differential protein expression profiles of chased from ABSciex, Framingham, MA. Antibodies are de- cellular and plasma samples. These approaches are evolving tailed in Supplementary
Recommended publications
  • Species-Specific Difference in Expression and Splice-Site Choice In
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Springer - Publisher Connector Mamm Genome (2010) 21:458–466 DOI 10.1007/s00335-010-9281-7 Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome Susan P. Bothwell • Leslie W. Farber • Adam Hoagland • Robert L. Nussbaum Received: 11 June 2010 / Accepted: 31 August 2010 / Published online: 26 September 2010 Ó The Author(s) 2010. This article is published with open access at Springerlink.com Abstract The oculocerebrorenal syndrome of Lowe Inpp5b/INPP5B are the most highly conserved paralogs to (OCRL; MIM #309000) is an X-linked human disorder Ocrl/OCRL in the respective genomes of both species and characterized by congenital cataracts, mental retardation, Inpp5b demonstrates functional overlap with Ocrl in mice and renal proximal tubular dysfunction caused by loss-of- in vivo. We used in silico sequence analysis, reverse-tran- function mutations in the OCRL gene that encodes Ocrl, a scription PCR, quantitative PCR, and transient transfection type II phosphatidylinositol bisphosphate (PtdIns4,5P2) assays of promoter function to define splice-site usage and 5-phosphatase. In contrast, mice with complete loss-of- the function of an internal promoter in mouse Inpp5b function of the highly homologous ortholog Ocrl have no versus human INPP5B. We found mouse Inpp5b and detectable renal, ophthalmological, or central nervous human INPP5B differ in their transcription, splicing, and system abnormalities. We inferred that the disparate phe- primary amino acid sequence. These observations form the notype between Ocrl-deficient humans and mice was likely foundation for analyzing the functional basis for the dif- due to differences in how the two species compensate for ference in how Inpp5b and INPP5B compensate for loss of loss of the Ocrl enzyme.
    [Show full text]
  • Full-Length Cdna, Expression Pattern and Association Analysis of the Porcine FHL3 Gene
    1473 Asian-Aust. J. Anim. Sci. Vol. 20, No. 10 : 1473 - 1477 October 2007 www.ajas.info Full-length cDNA, Expression Pattern and Association Analysis of the Porcine FHL3 Gene Bo Zuo*, YuanZhu Xiong, Hua Yang and Jun Wang Key Laboratory of Swine Genetics and Breeding, Ministry of Agriculture & Key Lab of Agricultural Animal Genetics, Breeding and Reproduction, Ministry of Education, College of Animal Science and Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, P. R. China ABSTRACT : Four-and-a-half LIM-only protein 3 (FHL3) is a member of the LIM protein superfamily and can participate in mediating protein-protein interaction by binding one another through their LIM domains. In this study, the 5'- and 3'- cDNA ends were characterized by RACE (Rapid Amplification of the cDNA Ends) methodology in combination with in silica cloning based on the partial cDNA sequence obtained. Bioinformatics analysis showed FHL3 protein contained four LIM domains and four LIM zinc-binding domains. In silica mapping assigned this gene to the gene cluster MTF1-INPP5B-SF3A3-FHL3-CGI-94 on pig chromosome 6 where several QTL affecting intramuscular fat and eye muscle area had previously been identified. Transcription of the FHL3 gene was detected in spleen, liver, kidney, small intestine, skeletal muscle, fat and stomach, with the greatest expression in skeletal muscle. The A/G polymorphism in exon II was significantly associated with birth weight, average daily gain before weaning, drip loss rate, water holding capacity and intramuscular fat in a Landrace-derived pig population. Together, the present study provided the useful information for further studies to determine the roles of FHL3 gene in the regulation of skeletal muscle cell growth and differentiation in pigs.
    [Show full text]
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
    [Show full text]
  • Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model
    BASIC RESEARCH www.jasn.org Effects of Proximal Tubule Shortening on Protein Excretion in a Lowe Syndrome Model Megan L. Gliozzi,1 Eugenel B. Espiritu,2 Katherine E. Shipman,1 Youssef Rbaibi,1 Kimberly R. Long,1 Nairita Roy,3 Andrew W. Duncan,3 Matthew J. Lazzara,4 Neil A. Hukriede,2,5 Catherine J. Baty,1 and Ora A. Weisz1 1Renal-Electrolyte Division, Department of Medicine, 2Department of Developmental Biology, and 3Department of Pathology, McGowan Institute for Regenerative Medicine, and Pittsburgh Liver Research Center, Pittsburgh, Pennsylvania; 4Department of Chemical Engineering, University of Virginia, Charlottesville, Virginia; and 5Center for Critical Care Nephrology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania ABSTRACT Background Lowe syndrome (LS) is an X-linked recessive disorder caused by mutations in OCRL,which encodes the enzyme OCRL. Symptoms of LS include proximal tubule (PT) dysfunction typically character- ized by low molecular weight proteinuria, renal tubular acidosis (RTA), aminoaciduria, and hypercalciuria. How mutant OCRL causes these symptoms isn’tclear. Methods We examined the effect of deleting OCRL on endocytic traffic and cell division in newly created human PT CRISPR/Cas9 OCRL knockout cells, multiple PT cell lines treated with OCRL-targeting siRNA, and in orcl-mutant zebrafish. Results OCRL-depleted human cells proliferated more slowly and about 10% of them were multinucleated compared with fewer than 2% of matched control cells. Heterologous expression of wild-type, but not phosphatase-deficient, OCRL prevented the accumulation of multinucleated cells after acute knockdown of OCRL but could not rescue the phenotype in stably edited knockout cell lines. Mathematic modeling confirmed that reduced PT length can account for the urinary excretion profile in LS.
    [Show full text]
  • Qt4ff4w947.Pdf
    eScholarship Title Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome Permalink https://escholarship.org/uc/item/4ff4w947 Journal Mammalian Genome, 21(9) ISSN 1432-1777 Authors Bothwell, Susan P. Farber, Leslie W. Hoagland, Adam et al. Publication Date 2010-10-01 DOI 10.1007/s00335-010-9281-7 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Mamm Genome (2010) 21:458–466 DOI 10.1007/s00335-010-9281-7 Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome Susan P. Bothwell • Leslie W. Farber • Adam Hoagland • Robert L. Nussbaum Received: 11 June 2010 / Accepted: 31 August 2010 / Published online: 26 September 2010 Ó The Author(s) 2010. This article is published with open access at Springerlink.com Abstract The oculocerebrorenal syndrome of Lowe Inpp5b/INPP5B are the most highly conserved paralogs to (OCRL; MIM #309000) is an X-linked human disorder Ocrl/OCRL in the respective genomes of both species and characterized by congenital cataracts, mental retardation, Inpp5b demonstrates functional overlap with Ocrl in mice and renal proximal tubular dysfunction caused by loss-of- in vivo. We used in silico sequence analysis, reverse-tran- function mutations in the OCRL gene that encodes Ocrl, a scription PCR, quantitative PCR, and transient transfection type II phosphatidylinositol bisphosphate (PtdIns4,5P2) assays of promoter function to define splice-site usage and 5-phosphatase. In contrast, mice with complete loss-of- the function of an internal promoter in mouse Inpp5b function of the highly homologous ortholog Ocrl have no versus human INPP5B.
    [Show full text]
  • ARID2 Deficiency Promotes Tumor Progression and Is Associated with Higher
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.10.898726; this version posted January 10, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to PARP inhibition in lung cancer. Thaidy Moreno1, Laura González-Silva1, Beatriz Monterde1, Isabel Betancor-Fernández2, Carlos Revilla1, Antonio Agraz-Doblas1, Javier Freire3, Pablo Isidro4, Laura Quevedo1, Santiago Montes-Moreno3, Laura Cereceda3, Aurora Astudillo4, Berta Casar1,6, Piero Crespo1,6, Cristina Morales Torres5, Paola Scaffidi5,7, Javier Gomez-Roman3, Eduardo Salido2, and Ignacio Varela1* 1) Instituto de Biomedicina y Biotecnología de Cantabria. Universidad de Cantabria-CSIC. Santander, Spain. 2) Departamento de Patología, Centro de Investigación Biomédica en Red de Enfermedades Raras by impairing DNA repair. Importantly, our results indicate that ARID2-deficiency could be(CIBERER). Tenerife, Spain. 3) Servicio de Anatomía Patológica y Biobanco Valdecilla. HUMV/IDIVAL. Santander, Spain. 4) Biobanco del Principado de Asturias (BBPA). Hospital Universitario Central de Asturias. Oviedo, Spain. 5) Cancer Epigenetics Laboratory, The Francis Crick Institute. London, UK. 6) Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) 7) UCL Cancer Institute, London, UK. * To whom correspondence should be addressed: Ignacio Varela Instituto de Biomedicina y Biotecnología de Cantabria Universidad de Cantabria Albert Einstein 22, 39011 Santander Spain. Ph. +34 942203931 Email. [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.01.10.898726; this version posted January 10, 2020.
    [Show full text]
  • European Journal of Immunology
    European Journal of Immunology Supporting Information for Eur. J. Immunol. 10.1002/eji.200535496 Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis Antje Kahnert, Peter Seiler, Maik Stein, Silke Bandermann, Karin Hahnke, Hans Mollenkopf and Stefan H. E. Kaufmann © 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji.de ΣΣΣ ↑↓ 163 ↑ 143 > 0 anticorrelated ↓ 20 I III II ↑↓ 105 ↑↓ 39 ↑↓ 19 ↑ 86 ↓ 19 ↑ 38 ↓ 1 ↑ 19 ↓ 0 IFN- γγγ 4h IL-4 4h ↑↓ 144 ↑↓ 58 ↑ 124 ↓ 20 ↑ 57 ↓ 1 ΣΣΣ ↑↓ 1331 ↑ 680 > 41 anticorrelated ↓ 692 IV VI V ↑↓ 943 ↑↓ 159 ↑↓ 229 ↑ 411 ↓ 573 ↑ 72 ↓ 46 ↑ 197 ↓ 73 IFN- γγγ 48h IL-4 48h ↑↓ 1102 ↑↓ 388 ↑ 483 ↓ 619 ↑ 269 ↓ 119 IFN- γγγ 4h IL-4 4h Group Fold Change P-value Intensity1 Intensity2 Fold Change P-value Intensity1 Intensity2 Accession # Primary Sequence Name Sequence Description I ↑↑↑ 4.37371 3.18166E-32 657.5683 2877.62183 1.52007 0.22311 124.05638 189.28168 NM_008042 Fprl1 formyl peptide receptor-like 1 I ↑↑↑ 5.19517 2.30606E-23 3173.28125 16666.12305 1.24572 0.04476 1087.70605 1344.94006 NM_011315 Saa3 serum amyloid A 3 I ↑↑↑ 2.05258 3.2031E-06 1358.04822 2813.76611 1.10341 0.60242 697.22046 783.63538 NM_008518 Ltb lymphotoxin B I ↑↑↑ 2.62754 1.24797E-11 3477.42529 9092.96484 1.10201 0.29205 910.6438 1004.36945 NM_008357 Il15 interleukin 15 I ↑↑↑ 2.19028 5.38095E-09 1189.62219 2618.71338 1.83042 0.00007 367.65424 674.255 NM_007548 Prdm1 PR domain containing 1, with ZNF domain I ↑↑↑ 3.16446 4.00706E-07 520.12781 1650.31921 2.23118 0.10955 76.51717 166.07359 NM_009421
    [Show full text]
  • CREB-Dependent Transcription in Astrocytes: Signalling Pathways, Gene Profiles and Neuroprotective Role in Brain Injury
    CREB-dependent transcription in astrocytes: signalling pathways, gene profiles and neuroprotective role in brain injury. Tesis doctoral Luis Pardo Fernández Bellaterra, Septiembre 2015 Instituto de Neurociencias Departamento de Bioquímica i Biologia Molecular Unidad de Bioquímica y Biologia Molecular Facultad de Medicina CREB-dependent transcription in astrocytes: signalling pathways, gene profiles and neuroprotective role in brain injury. Memoria del trabajo experimental para optar al grado de doctor, correspondiente al Programa de Doctorado en Neurociencias del Instituto de Neurociencias de la Universidad Autónoma de Barcelona, llevado a cabo por Luis Pardo Fernández bajo la dirección de la Dra. Elena Galea Rodríguez de Velasco y la Dra. Roser Masgrau Juanola, en el Instituto de Neurociencias de la Universidad Autónoma de Barcelona. Doctorando Directoras de tesis Luis Pardo Fernández Dra. Elena Galea Dra. Roser Masgrau In memoriam María Dolores Álvarez Durán Abuela, eres la culpable de que haya decidido recorrer el camino de la ciencia. Que estas líneas ayuden a conservar tu recuerdo. A mis padres y hermanos, A Meri INDEX I Summary 1 II Introduction 3 1 Astrocytes: physiology and pathology 5 1.1 Anatomical organization 6 1.2 Origins and heterogeneity 6 1.3 Astrocyte functions 8 1.3.1 Developmental functions 8 1.3.2 Neurovascular functions 9 1.3.3 Metabolic support 11 1.3.4 Homeostatic functions 13 1.3.5 Antioxidant functions 15 1.3.6 Signalling functions 15 1.4 Astrocytes in brain pathology 20 1.5 Reactive astrogliosis 22 2 The transcription
    [Show full text]
  • Robles JTO Supplemental Digital Content 1
    Supplementary Materials An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma based on mRNA, microRNA and DNA Methylation Biomarkers Ana I. Robles1, Eri Arai2, Ewy A. Mathé1, Hirokazu Okayama1, Aaron Schetter1, Derek Brown1, David Petersen3, Elise D. Bowman1, Rintaro Noro1, Judith A. Welsh1, Daniel C. Edelman3, Holly S. Stevenson3, Yonghong Wang3, Naoto Tsuchiya4, Takashi Kohno4, Vidar Skaug5, Steen Mollerup5, Aage Haugen5, Paul S. Meltzer3, Jun Yokota6, Yae Kanai2 and Curtis C. Harris1 Affiliations: 1Laboratory of Human Carcinogenesis, NCI-CCR, National Institutes of Health, Bethesda, MD 20892, USA. 2Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. 3Genetics Branch, NCI-CCR, National Institutes of Health, Bethesda, MD 20892, USA. 4Division of Genome Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan. 5Department of Chemical and Biological Working Environment, National Institute of Occupational Health, NO-0033 Oslo, Norway. 6Genomics and Epigenomics of Cancer Prediction Program, Institute of Predictive and Personalized Medicine of Cancer (IMPPC), 08916 Badalona (Barcelona), Spain. List of Supplementary Materials Supplementary Materials and Methods Fig. S1. Hierarchical clustering of based on CpG sites differentially-methylated in Stage I ADC compared to non-tumor adjacent tissues. Fig. S2. Confirmatory pyrosequencing analysis of DNA methylation at the HOXA9 locus in Stage I ADC from a subset of the NCI microarray cohort. 1 Fig. S3. Methylation Beta-values for HOXA9 probe cg26521404 in Stage I ADC samples from Japan. Fig. S4. Kaplan-Meier analysis of HOXA9 promoter methylation in a published cohort of Stage I lung ADC (J Clin Oncol 2013;31(32):4140-7). Fig. S5. Kaplan-Meier analysis of a combined prognostic biomarker in Stage I lung ADC.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • 393LN V 393P 344SQ V 393P Probe Set Entrez Gene
    393LN v 393P 344SQ v 393P Entrez fold fold probe set Gene Gene Symbol Gene cluster Gene Title p-value change p-value change chemokine (C-C motif) ligand 21b /// chemokine (C-C motif) ligand 21a /// chemokine (C-C motif) ligand 21c 1419426_s_at 18829 /// Ccl21b /// Ccl2 1 - up 393 LN only (leucine) 0.0047 9.199837 0.45212 6.847887 nuclear factor of activated T-cells, cytoplasmic, calcineurin- 1447085_s_at 18018 Nfatc1 1 - up 393 LN only dependent 1 0.009048 12.065 0.13718 4.81 RIKEN cDNA 1453647_at 78668 9530059J11Rik1 - up 393 LN only 9530059J11 gene 0.002208 5.482897 0.27642 3.45171 transient receptor potential cation channel, subfamily 1457164_at 277328 Trpa1 1 - up 393 LN only A, member 1 0.000111 9.180344 0.01771 3.048114 regulating synaptic membrane 1422809_at 116838 Rims2 1 - up 393 LN only exocytosis 2 0.001891 8.560424 0.13159 2.980501 glial cell line derived neurotrophic factor family receptor alpha 1433716_x_at 14586 Gfra2 1 - up 393 LN only 2 0.006868 30.88736 0.01066 2.811211 1446936_at --- --- 1 - up 393 LN only --- 0.007695 6.373955 0.11733 2.480287 zinc finger protein 1438742_at 320683 Zfp629 1 - up 393 LN only 629 0.002644 5.231855 0.38124 2.377016 phospholipase A2, 1426019_at 18786 Plaa 1 - up 393 LN only activating protein 0.008657 6.2364 0.12336 2.262117 1445314_at 14009 Etv1 1 - up 393 LN only ets variant gene 1 0.007224 3.643646 0.36434 2.01989 ciliary rootlet coiled- 1427338_at 230872 Crocc 1 - up 393 LN only coil, rootletin 0.002482 7.783242 0.49977 1.794171 expressed sequence 1436585_at 99463 BB182297 1 - up 393
    [Show full text]
  • An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
    The Journal of Neuroscience, September 3, 2014 • 34(36):11929–11947 • 11929 Cellular/Molecular An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex Ye Zhang,1* Kenian Chen,2,3* Steven A. Sloan,1* Mariko L. Bennett,1 Anja R. Scholze,1 Sean O’Keeffe,4 Hemali P. Phatnani,4 XPaolo Guarnieri,7,9 Christine Caneda,1 Nadine Ruderisch,5 Shuyun Deng,2,3 Shane A. Liddelow,1,6 Chaolin Zhang,4,7,8 Richard Daneman,5 Tom Maniatis,4 XBen A. Barres,1† and XJia Qian Wu2,3† 1Department of Neurobiology, Stanford University School of Medicine, Stanford, California 94305-5125, 2The Vivian L. Smith Department of Neurosurgery, University of Texas Medical School at Houston, Houston, Texas 77057, 3Center for Stem Cell and Regenerative Medicine, University of Texas Brown Institute of Molecular Medicine, Houston, Texas 77057, 4Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, New York 10032, 5Department of Anatomy, University of California, San Francisco, San Francisco, California 94143-0452, 6Department of Pharmacology and Therapeutics, University of Melbourne, Parkville, Victoria, Australia 3010, and 7Department of Systems Biology, 8Center for Motor Neuron Biology and Disease, and 9Herbert Irving Comprehensive Cancer Center, Columbia University, New York, New York 10032 The major cell classes of the brain differ in their developmental processes, metabolism, signaling, and function. To better understand the functions and interactions of the cell types that comprise these classes, we acutely purified representative populations of neurons, astrocytes, oligodendrocyte precursor cells, newly formed oligodendrocytes, myelinating oligodendrocytes, microglia, endothelial cells, and pericytes from mouse cerebral cortex.
    [Show full text]